fernando rodríguez-serrano
University of Granada
Granada, Spain
Review Editor
Pharmacology of Anti-Cancer Drugs
Editors
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Editorial board
Type at least 3 characters
Editors
Shape the future of research in your field
Join the board
Review Editors
robert a. rollins
Pfizer
New York, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
giovanni rossi
University of Sassari
Sassari, Italy
Review Editor
Pharmacology of Anti-Cancer Drugs
saartjie roux
Nelson Mandela University
Port Elizabeth, South Africa
Review Editor
Pharmacology of Anti-Cancer Drugs
neha roy
Kangwon National University
Chuncheon, Republic of Korea
Review Editor
Pharmacology of Anti-Cancer Drugs
swathi roy
Bronx-Lebanon Hospital Center
New York, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
mithun rudrapal
Vignan's Foundation for Science, Technology and Research
Guntur, India
Review Editor
Pharmacology of Anti-Cancer Drugs
maria russo
Institute of Food Sciences, National Research Council (CNR)
Avellino, Italy
Review Editor
Pharmacology of Anti-Cancer Drugs
violaine see
University of Liverpool
Liverpool, United Kingdom
Review Editor
Pharmacology of Anti-Cancer Drugs
jia-wen shou
University of Wisconsin-Madison
Madison, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
hemlata sukhija
City of Hope National Medical Center
Duarte, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
miguel saceda
Miguel Hernández University of Elche
Elche, Spain
Review Editor
Pharmacology of Anti-Cancer Drugs
selma sahin
Hacettepe University
Ankara, Türkiye
Review Editor
Pharmacology of Anti-Cancer Drugs
neveen said
Wake Forest Baptist Medical Center
Winston-Salem, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
md sanaullah sajib
United States Food and Drug Administration
Silver Spring, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
gianluca sala
University of Studies G. d'Annunzio Chieti and Pescara
Chieti, Italy
Review Editor
Pharmacology of Anti-Cancer Drugs